Premium
Akebia Therapeutics Inc (AKBA)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment... Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.07 | -3.19634703196 | 2.19 | 2.215 | 2.08 | 1382527 | 2.11965226 | CS |
| 4 | 0.17 | 8.71794871795 | 1.95 | 2.41 | 1.9 | 2226708 | 2.20708081 | CS |
| 12 | 0.31 | 17.1270718232 | 1.81 | 2.41 | 1.715 | 2173588 | 2.01127189 | CS |
| 26 | 0.88 | 70.9677419355 | 1.24 | 2.41 | 1.23 | 1967130 | 1.7847858 | CS |
| 52 | 0.5 | 30.8641975309 | 1.62 | 2.48 | 0.8 | 2911955 | 1.58609788 | CS |
| 156 | 0.37 | 21.1428571429 | 1.75 | 2.93 | 0.241 | 3564926 | 0.9973081 | CS |
| 260 | -6.66 | -75.854214123 | 8.78 | 13.78 | 0.241 | 3676197 | 2.19337857 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
